NCT06322667 A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab Status RECRUITING Phase N/A
NCT06285240 Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007) Status COMPLETED Phase PHASE1
NCT06245616 Attenuation of Postprandial Inflammatory Processes in Alzheimer's Disease Patients by Consumption of Pomace Oil Status ACTIVE_NOT_RECRUITING Phase NA
NCT06234930 The Feasibility, Safety and Tolerability of VR-based Audiovisual Stimulation Status COMPLETED Phase NA
NCT06206824 Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT06199037 Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients Status TERMINATED Phase PHASE2
NCT06141356 [18F]Florbetazine ([18F]92) for Beta Amyloid PET Imaging in Alzheimer's Disease Status RECRUITING Phase N/A
NCT06088121 Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia Status RECRUITING Phase NA
NCT06079190 Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06043700 A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05978830 Development of Multimodal Fusion Warning System and Non-invasive Techniques for Early Alzheimer's Detection. Status UNKNOWN Phase NA
NCT05965414 Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers Status COMPLETED Phase EARLY_PHASE1
NCT05908695 An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease Status RECRUITING Phase PHASE4
NCT05837819 Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2 Status COMPLETED Phase NA
NCT05811442 Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT05804383 A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT05792163 A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT05787028 Safety, Tolerability and Pharmacokinetics of AD16 Tablets in Adult Healthy Subjects After Single Administration Status COMPLETED Phase PHASE1